Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma

Area of Science:

• Oncology
• Genomics
• Molecular Biology

Background:

• Renal cell carcinoma (RCC) is a heterogeneous cancer with diverse histologic types.
• Understanding the molecular underpinnings of RCC is crucial for developing targeted therapies.

Purpose of the Study:

• To classify a large cohort of renal cell carcinomas (RCCs) into distinct genomic subtypes.
• To identify molecular drivers and pathway alterations associated with each subtype.
• To explore the relationship between genomic subtypes, tumor microenvironment, and patient survival.

Main Methods:

• Multidimensional molecular characterization of 894 RCCs, including DNA methylation, copy number, RNA, and protein expression.
• Genomic subtyping based on integrated molecular data.
• Analysis of pathway alterations, TFE3 gene fusions, and chromatin modifier genes.
• Correlation of genomic subtypes with immune checkpoint markers, T cell infiltrates, and patient survival.

Main Results:

• Nine major genomic subtypes of RCC were identified, reflecting differences in site of origin within the nephron.
• Specific subtypes were characterized by TFE3 gene fusions or alterations in chromatin modifier genes.
• Subtypes differed in pathway alterations (hypoxia, metabolism, immune checkpoint, etc.) and patient survival.
• The subtype associated with aggressive clear cell RCC exhibited the highest immune checkpoint markers and T cell infiltrates.

Conclusions:

• Comprehensive molecular profiling enables the classification of RCC into distinct genomic subtypes.
• These subtypes are associated with specific molecular drivers, pathway alterations, and clinical outcomes.
• Genomic subtyping provides a framework for tailoring therapeutic strategies to individual RCC patient subsets.